Literature DB >> 3310307

The K veim response: still useful, still a puzzle.

C S Munro1, D N Mitchell.   

Abstract

Mesh：

Year:  1987        PMID： 3310307      PMCID： PMC460750          DOI： 10.1136/thx.42.5.321

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  50 in total

1.  Objective evaluation of the Kveim test in a "double-blind" study.

Authors:  M KENNEY; D J STONE
Journal:  Am Rev Respir Dis       Date:  1963-04

2.  The preparation and standardization of Kveim testing antigen.

Authors:  M W CHASE
Journal:  Am Rev Respir Dis       Date:  1961-11

3.  Immunohistological development of the Kveim reaction.

Authors:  M Hannuksela; O P Salo; J Karvonen
Journal:  Dermatologica       Date:  1975

4.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

Review 5.  Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature.

Authors:  J D Stoeckle; H L Hardy; A L Weber
Journal:  Am J Med       Date:  1969-04       Impact factor: 4.965

6.  Lymphocyte sensitization in sarcoidosis.

Authors:  E A Caspary; E J Field
Journal:  Br Med J       Date:  1971-04-17

7.  Leukocyte migration agarose test (LMAT) in sarcoidosis using Kveim test material.

Authors:  M Horsmanheimo; A Horsmanheimo; H H Fudenberg; L E Siltzbach; K T McKee
Journal:  Br J Dermatol       Date:  1978-09       Impact factor: 9.302

8.  The nature of the Kveim reaction.

Authors:  R Kooij
Journal:  Acta Med Scand Suppl       Date:  1964

9.  The distribution of lymphoid and macrophage like cell subsets of sarcoid and Kveim granulomata: possible mechanism of negative PPD reaction in sarcoidosis.

Authors:  B B Mishra; L W Poulter; G Janossy; D G James
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

10.  Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations.

Authors:  G Semenzato; C Agostini; R Zambello; L Trentin; M Chilosi; M R Angi; E Ossi; A Cipriani; G Pizzolo
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691
View more
  8 in total

Review 1.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

Review 2.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 3.  Atypical Cutaneous Presentations of Sarcoidosis: Two Case Reports and Review of the Literature.

Authors:  David L Leverenz; Christopher Henderson; Ankoor Shah
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-14       Impact factor: 4.806

Review 4.  Potential etiologic agents in sarcoidosis.

Authors:  David R Moller
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

5.  Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

Authors:  Edward S Chen; Zhimin Song; Matthew H Willett; Shannon Heine; Rex C Yung; Mark C Liu; Steve D Groshong; Ying Zhang; Rubin M Tuder; David R Moller
Journal:  Am J Respir Crit Care Med       Date:  2009-11-12       Impact factor: 21.405

6.  Development of a T7 Phage Display Library to Detect Sarcoidosis and Tuberculosis by a Panel of Novel Antigens.

Authors:  Harvinder Talwar; Rita Rosati; Jia Li; Dana Kissner; Samiran Ghosh; Félix Fernández -Madrid; Lobelia Samavati
Journal:  EBioMedicine       Date:  2015-04-01       Impact factor: 8.143

Review 7.  Making sense of the cause of Crohn's - a new look at an old disease.

Authors:  Anthony W Segal
Journal:  F1000Res       Date:  2016-10-12

8.  Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.

Authors:  Zhimin Song; Lisa Marzilli; Brian M Greenlee; Edward S Chen; Richard F Silver; Frederic B Askin; Alvin S Teirstein; Ying Zhang; Robert J Cotter; David R Moller
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.